229 related articles for article (PubMed ID: 23645210)
1. Genetic deletion of caspase-2 accelerates MMTV/c-neu-driven mammary carcinogenesis in mice.
Parsons MJ; McCormick L; Janke L; Howard A; Bouchier-Hayes L; Green DR
Cell Death Differ; 2013 Sep; 20(9):1174-82. PubMed ID: 23645210
[TBL] [Abstract][Full Text] [Related]
2. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T
Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838
[TBL] [Abstract][Full Text] [Related]
3. An unexpected role for caspase-2 in neuroblastoma.
Dorstyn L; Puccini J; Nikolic A; Shalini S; Wilson CH; Norris MD; Haber M; Kumar S
Cell Death Dis; 2014 Aug; 5(8):e1383. PubMed ID: 25144718
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome profiling of caspase-2 deficient EμMyc and Th-MYCN mouse tumors identifies distinct putative roles for caspase-2 in neuronal differentiation and immune signaling.
Dorstyn L; Hackett-Jones E; Nikolic A; Norris MD; Lim Y; Toubia J; Haber M; Kumar S
Cell Death Dis; 2019 Jan; 10(2):56. PubMed ID: 30670683
[TBL] [Abstract][Full Text] [Related]
5. In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.
Hosokawa Y; Papanikolaou A; Cardiff RD; Yoshimoto K; Bernstein M; Wang TC; Schmidt EV; Arnold A
Transgenic Res; 2001 Oct; 10(5):471-8. PubMed ID: 11708657
[TBL] [Abstract][Full Text] [Related]
6. Hemizygous disruption of Cdc25A inhibits cellular transformation and mammary tumorigenesis in mice.
Ray D; Terao Y; Nimbalkar D; Hirai H; Osmundson EC; Zou X; Franks R; Christov K; Kiyokawa H
Cancer Res; 2007 Jul; 67(14):6605-11. PubMed ID: 17638870
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
[TBL] [Abstract][Full Text] [Related]
8. MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer.
Taneja P; Frazier DP; Kendig RD; Maglic D; Sugiyama T; Kai F; Taneja NK; Inoue K
Expert Rev Mol Diagn; 2009 Jul; 9(5):423-40. PubMed ID: 19580428
[TBL] [Abstract][Full Text] [Related]
9. Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.
Strumane K; Rygiel T; van der Valk M; Collard JG
J Cancer Res Clin Oncol; 2009 Jan; 135(1):69-80. PubMed ID: 18592271
[TBL] [Abstract][Full Text] [Related]
10. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.
Podsypanina K; Li Y; Varmus HE
BMC Med; 2004 Jun; 2():24. PubMed ID: 15198801
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Notch1 in the development of mouse mammary tumors.
Diévart A; Beaulieu N; Jolicoeur P
Oncogene; 1999 Oct; 18(44):5973-81. PubMed ID: 10557086
[TBL] [Abstract][Full Text] [Related]
12. MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Guo C; Yuan F; Li YJ; Archer MC; Zacksenhaus E; Windle JJ; Subler MA; Ben-David Y; Sarkar D; Wang XY; Fisher PB
Oncotarget; 2015 Nov; 6(35):36928-42. PubMed ID: 26474456
[TBL] [Abstract][Full Text] [Related]
13. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
[TBL] [Abstract][Full Text] [Related]
14. neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice.
Li B; Rosen JM; McMenamin-Balano J; Muller WJ; Perkins AS
Mol Cell Biol; 1997 Jun; 17(6):3155-63. PubMed ID: 9154814
[TBL] [Abstract][Full Text] [Related]
15. A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice.
Little JL; Serzhanova V; Izumchenko E; Egleston BL; Parise E; Klein-Szanto AJ; Loudon G; Shubina M; Seo S; Kurokawa M; Ochs MF; Golemis EA
Oncogene; 2014 Jan; 33(4):411-20. PubMed ID: 23318423
[TBL] [Abstract][Full Text] [Related]
16. Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice.
Jamerson MH; Johnson MD; Korsmeyer SJ; Furth PA; Dickson RB
Br J Cancer; 2004 Oct; 91(7):1372-9. PubMed ID: 15354213
[TBL] [Abstract][Full Text] [Related]
17. Caspase-2 deficiency promotes aberrant DNA-damage response and genetic instability.
Dorstyn L; Puccini J; Wilson CH; Shalini S; Nicola M; Moore S; Kumar S
Cell Death Differ; 2012 Aug; 19(8):1288-98. PubMed ID: 22498700
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
Zinser GM; Welsh J
Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice.
Ritland SR; Rowse GJ; Chang Y; Gendler SJ
Cancer Res; 1997 Aug; 57(16):3520-5. PubMed ID: 9270023
[TBL] [Abstract][Full Text] [Related]
20. Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.
Zhang C; Mori M; Gao S; Li A; Hoshino I; Aupperlee MD; Haslam SZ; Xiao H
Cancer Res; 2010 Dec; 70(24):10224-33. PubMed ID: 21159643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]